Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Mehregan Babamohamadi(University of Tabriz), Jamshid Hadjati(Aja University of Medical Sciences), Roshanak Amirian(Kermanshah University of Medical Sciences), Zhila Izadi(Razi University), Amirhossein Merati(Kermanshah University of Medical Sciences), Maryam Haddadi(Kermanshah University of Medical Sciences), Elham Faryadi(Kermanshah University of Medical Sciences), Farbod Ghobadinezhad(Kermanshah University of Medical Sciences)
Cited by 83
Related Papers
Recent findings on the role of wild-type and mutant p53 in cancer development and therapy
|Frontiers in Molecular Biosciences|2022|31
Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment
|Cellular and Molecular Neurobiology|2022|21
Types of RNA therapeutics
|Progress in molecular biology and translational science|2024|14
Phytostilbenes in lymphoma: Focuses on the mechanistic and clinical prospects of resveratrol, pterostilbene, piceatannol, and pinosylvin
|Leukemia Research|2024|14
Recent advances in targeting LRRK2 for Parkinson’s disease treatment
|Journal of Translational Medicine|2025|14